Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
Date:8/6/2009

----- --------------------------------------- --------------------------------- --------------------------------------- Net income (loss) for the period $ 567 $ (1,449) $ (882) --------------------------------- --------------------------------------- Basic and diluted net income (loss) per common share $ 0.01 $ (0.01) --------------------------------- --------------------------------------- --------------------------------- --------------------------------------- Weighted average shares outstanding (000's) - basic and diluted 85,122 85,122 --------------------------------- --------------------------------------- (in thousands of U.S.$, except Six months ended share and per share data) June 30, 2008 ------------------------------------------------------------------------- Reported Adjustments Adjusted REVENUE Royalty revenue $ 54,465 $ - $ 54,465 Product sales, net 98,259 - 98,259 License fees 106 (106) a - --------------------------------- --------------------------------------- 152,830 (106) 152,724 --------------------------------- --------------------------------------- EXPENSES License and royalty fees 8,032 - 8,032 Cost of products sold 52,658 (28) b 52,630 Research and development 34,889 (2,932) c 31,957 Selling, general and administrative 53,654 (6,718) d 46,936 Depreciation and amortization 17,017 (15,178) e 1,839 In-process research and de
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
11. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... July 31, 2015 In today,s fast ... help them drive positive health outcomes, improve profitability ... of patient care in their communities. At ThoughtSpot ... and conference, AmerisourceBergen announced a new set of ... Administration Organization and help independent pharmacies endure the ...
(Date:7/30/2015)... ... July 31, 2015 , ... Ralco is honored to announce that ... County Fair to be held August 5-9 in Marshall. The Ralco Enrichment Center is ... from and how agriculture impacts their daily lives. This unique exhibit also features a ...
(Date:7/30/2015)... ... 30, 2015 , ... The 2015 Market Research Report on the Global ... the global Propanol market with a focus on the Chinese situation. Major companies included ... Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , ...
(Date:7/30/2015)... 30, 2015   Senomyx , Inc. (NASDAQ: ... technologies to discover, develop, and commercialize novel flavor ingredients ... reported financial results for the second quarter 2015. ... we remain on track to achieve our commercial and ... Officer of the Company. "Since our last quarterly earnings ...
Breaking Biology Technology:AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 2AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 3Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9
... , July 21 Chimerix, Inc., a biotechnology company ... clinical management team with the appointment of Timothy King , ... as Vice President of Clinical Research.   , ... In these new roles, Mr. King ...
... July 21 United Therapeutics Corporation (Nasdaq: UTHR ) announced ... market open on Wednesday, July 28, 2010 . , ... United Therapeutics will host a half-hour teleconference ... Time .  The teleconference is accessible by dialing 1-877-351-5881, with international callers ...
... SEATTLE, Washington, July 20, 2010The Life Sciences Discovery ... four Washington state-based research teams to support commercial ... concentrate on improving the success rate of lumbar ... and more effective magnetic resonance imaging (MRI) contrast ...
Cached Biology Technology:Chimerix Appoints Two New Vice Presidents to Clinical Management Team 2Chimerix Appoints Two New Vice Presidents to Clinical Management Team 3Life Sciences Discovery Fund announces commercialization grants 2
(Date:7/13/2015)... July 13, 2015 Synaptics Inc. (NASDAQ: ... interface solutions, today announced sampling of ClearPad ® ... driver integration (TDDI) product targeting smartphones and tablets. ... combine Synaptics , best-in-class touch controller IP ... technology developed in the company,s Japan Design Center. ...
(Date:7/9/2015)... SAN JOSE, Calif. , July 9, ... ), the leading developer of human interface ... authentication technology, the industry,s first fully hardware ... innovative Match-in-Sensor secure authentication technology is literally ... pattern storage and biometric matching within the ...
(Date:7/7/2015)... , June 30, 2015 ... has announced the addition of the "Capacitive ... offering. To this date, fingerprint sensing ... technology and fingerprint sensors are well developed. This ... sensing technology. The domain of capacitive ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
... The best views of the hydrocarbon lakes and seas on ... released today. A new radar image comprised from seven ... a north pole pitted with giant lakes and seas, at ... USA, the largest freshwater lake on Earth. Approximately 60% of ...
... Pennsylvania have discovered that the nuclei of human stem ... making it easier for stem cells to migrate through ... to put human genes in the correct nuclear sector ... into microscopic glass tubes under controlled pressures and visualized ...
... we find out about the future dangers it poses" What ... climate for several hundred thousand years, complete with samples of ... lab for analysis. Incredibly, this record exists, in the icecaps ... Foundation programme has a key role in deciphering it. ...
Cached Biology News:Cassini's new view of land of lakes and seas 2Stem cell nuclei are soft 'hard drives,' Penn study finds 2European lead in reading past climates from ice cores 2European lead in reading past climates from ice cores 3
Request Info...
Amyloid stain....
Dopamine D2 and D3 receptor, human and possibly mouse. AB1502 detects 40 ng of dopamine receptor peptide by ELISA. AB1502 is not neutralizing....
Rabbit polyclonal to Factor IX ( Abpromise for all tested applications). entrezGeneID: 2158 SwissProtID: P00740...
Biology Products: